Operator

Good day, and welcome to the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026. Our next presenting company is RenovoRx Inc. [Operator Instructions]

I'd now like to turn the floor over to today's host, Shaun Bagai, Chief Executive Officer of RenovoRx Inc. Please go ahead.

Shaun Bagai
CEO, Secretary & Director

Thank you for the introduction, and thank you for the opportunity here, and thanks, everyone, for joining in. Shaun Bagai here, CEO of RenovoRx, and I'm also joined by my CFO, Chief Financial Officer, Mark Voll, who will chime in at the appropriate times.

So I wanted to give you a little overview on our company, our background, how the technology works and the opportunities that lay ahead of us. When we think about cancer and therapies in cancer, it's quite often a balance of trying to attack a tumor and not destroying the patient in the meantime. And what we've seen with therapeutic after therapeutic that the biggest blockbusters are, let's try to extend life by a few weeks to months. And hopefully, we don't have the worst possible ever quality life for patients. And it's that kind of balance and give and take on both sides.

At RenovoRx, we're trying to attack this very differently on is there a way that we can actually attack the tumor, keep the tumor at bay, extend life and also not destroy the patient in the process and maintain a relatively high quality of life and full function. And it looks like we're starting to achieve that.

So as a background, I'll go to